CKD-508 Tablet
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
HealthyHealthy Subjects
Phase 1
Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
CompletedNCT04488900
Start: 2020-07-06End: 2023-07-02Updated: 2024-02-15
A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants
CompletedNCT06727396
Start: 2024-11-14End: 2025-06-05Updated: 2026-02-27
A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants
CompletedNCT06979973
Start: 2025-05-14End: 2025-08-17Updated: 2026-02-27